The lead shield is made from a new, tungsten based radiation shielding compound that tests show to have a shielding effectiveness of 100% lead equivalent and weighs only 1.63kg
Now available from Southern Scientific is a lead shield accessory for the Amici Swirler aerosol nebuliser that makes it ideal for radionuclide lung imaging using DTPA.
The Amici Swirler is designed for ventilation lung imaging and meets the EU single-use directive.
The lead shield is made from a new, tungsten based radiation shielding compound that tests show to have a shielding effectiveness of 100% lead equivalent and weighs only 1.63kg.
It provides effective protection at all times and ensures that DTPA studies are entirely safe as all injections are completely self-contained and no hot spots occur outside the unit.
The unique features and the low cost of the Amici Swirler, that is safer, more efficient and less costly than other types of nebuliser, overcomes the highly emotive issues resulting from the recent ruling that technicians are individually responsible for the results of cross contamination.
All previous nebulisers rely on a jetting (venturi) technique to produce the aerosol whereas the patented airflow design of the Amici Swirler uses high shear forces to create efficient atomisation.
This increases the delivery of droplets of the required size to achieve a more rapid coating of the alveolar.
The increased rate of small particle production produces a higher quality diagnostic image and reduces procedure time.
A special, highly effective filtration system traps exhausted particles with maximum efficiency and a special media trap recovers aerosolised mist exhausted by the patient. This reduces the risk of contamination and provides added safety for attending personnel and the environment.
Manufactured from high quality plastics chosen for its high 'rain-off' properties allows valuable medicants to bead up for gravity rain-off rather than collecting on internal surfaces.
This means that less medication is required for each study, lowering the cost and reducing the dosage to the patient.